HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding the U.S. Food and Drug Administration (FDA) for releasing new data to help generic drug competitors:
Click here for the full statement.
Related Posts
New Analysis of U.S. Health Data Finds Healthcare Group Purchasing Organizations Save Healthcare System, Medicare and Medicaid, and Taxpayers Up to $34.1 Billion Annually
May 15, 2019
Analysis of CMS expenditure data finds that GPOs will reduce healthcare spending...
HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019
Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ethylene Oxide Sterilization of Medical Devices
December 12, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA CEO to Lead Panel Discussion on Innovation at AdvaMed’s MedTech Conference
September 23, 2019
Washington, DC (September 23, 2019) – The Healthcare Supply Chain...